Arvinas Inc (NASDAQ:ARVN)
| 68.58 Delayed Data As of 4:00pm ET |  +1.50 / +2.24%Today’s Change | 56.59 Today|||52-Week Range 108.47 | -16.51% Year-to-Date |
Latest ARVN News | Press Releases
No recent news for Arvinas Inc.
Today’s Trading
| Previous close | 67.08 |
| Today’s open | 66.66 |
| Day’s range | 65.94 - 69.50 |
| Volume | 35,526 |
| Average volume (3 months) | 395,129 |
| Market cap | $3.6B |
Data as of 4:00pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | -41.40% |
| Earnings growth (this year) | -15.64% |
| Earnings growth (next 5 years) | -3.54% |
| Revenue growth (last year) | -49.27% |
| P/E ratio | NM |
| Price/Sales | 154.01 |
| Price/Book | 5.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FATEFate Therapeutics In... | -0.61 | -1.53% |
| KODKodiak Sciences Inc | -4.65 | -7.76% |
| ---- | ||
| DNLIDenali Therapeutics ... | -0.47 | -1.39% |
Data as of 4:00pm ET, 01/26/2022
Financials
| Next reporting date | March 29, 2022 |
| EPS forecast (this quarter) | -$0.74 |
| Annual revenue (last year) | $21.8M |
| Annual profit (last year) | -$119.3M |
| Net profit margin | -547.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
